Ignite Creation Date:
2025-12-24 @ 1:49 PM
Ignite Modification Date:
2026-01-01 @ 6:16 AM
Study NCT ID:
NCT01102595
Status:
COMPLETED
Last Update Posted:
2015-08-26
First Post:
2010-04-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
Sponsor:
Grupo Español de Investigación en Neurooncología
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GENOM-009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None